Keyphrases
Tuberculosis
100%
Brazil
47%
India
38%
South Africa
36%
People Living with HIV (PLHIV)
27%
Isoniazid Preventive Therapy
23%
Pulmonary Tuberculosis
23%
Tuberculosis Diagnosis
21%
HIV Patients
21%
Tuberculosis Treatment Outcomes
20%
AIDS/HIV
19%
Active Tuberculosis
19%
Tuberculosis Incidence
19%
Tuberculin Skin Test
19%
Confidence Interval
18%
Type 1 Diabetes Mellitus (T1DM)
18%
Antiretroviral Therapy
18%
Tuberculosis Treatment
16%
Active Case Finding
15%
Pune
12%
Mycobacterium Tuberculosis (M. tb)
12%
Household Contacts
11%
Latent Tuberculosis Infection
11%
Tuberculosis Patients
11%
TB Treatment
11%
Treatment Outcome
10%
Risk Factors
10%
Incidence Rate
10%
Tuberculosis Preventive Therapy
10%
Cost-effectiveness
7%
Unfavorable Outcome
7%
Tuberculosis Disease
7%
CD4 Count
7%
High Risk
7%
Prospective Cohort Study
7%
Cluster Randomized Trial
7%
HIV-infected Adults
7%
HIV Clinics
7%
Tuberculosis Transmission
7%
Randomized Trial
6%
Highly Active Antiretroviral Therapy (HAART)
6%
Tuberculosis Control
6%
Smoking Cessation
6%
Home-based
6%
Esprito Santo
6%
Systematic Meta-analysis
6%
Meta-analysis
6%
High Prevalence
6%
Hazard Ratio
5%
Tuberculosis Prevention
5%
Medicine and Dentistry
Human Immunodeficiency Virus
84%
Tuberculosis
39%
Prophylaxis
36%
Lung Tuberculosis
27%
Case Finding
27%
Prevalence
26%
Household
24%
Disease
23%
Mantoux Test
20%
Isoniazid
20%
Symptom
20%
Tuberculosis Treatment
20%
Systematic Review
16%
Diabetes Mellitus
15%
Latent Tuberculosis
14%
Antiretroviral Therapy
13%
Mycobacterium Tuberculosis
12%
Cluster Randomized Trial
11%
Health Care
11%
Arm
10%
Diabetes
10%
Health Care Provider
10%
Health Care Cost
9%
Cost-Effectiveness Analysis
7%
Recurrent Disease
7%
Sputum
7%
Tuberculosis Diagnosis
7%
High Risk Population
6%
Contact Examination
6%
Skin Test
6%
Coughing
6%
Cohort Effect
6%
Multidrug Resistant Tuberculosis
6%
Meta-Analysis
6%
QuantiFERON
6%
Diagnosis
5%
Gene Linkage
5%
Hemoglobin A1c
5%
Highly Active Antiretroviral Therapy
5%
Tuberculin
5%
Sputum Smear
5%
Screening
5%
Cell Count
5%
Medical Record
5%